Kit for detecting nuclear factor-kappa B and application of kit
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIANGSU INST OF NUCLEAR MEDICINE
- Publication Date
- 2020-12-22
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of biotechnology, in particular to a kit for detecting nuclear factor-κB and its application. Background technique
[0002] At present, severe acute respiratory syndrome coronavirus (SARS-CoV-2) has swept the world, causing serious harm and impact on human health. The autopsy results showed that the pathological features of patients with new coronary pneumonia (COVID-19) suggested the occurrence of acute respiratory distress syndrome (ARDS), and the cause of ARDS was cytokine storm. When the virus invades cells, the release of nucleic acid RNA activates Toll-like receptor 7 (TLR7) and recruits multiple proteins to form a complex, thereby promoting transcription factors (TFs) such as interferon regulatory factor 7 (IRF7) and nuclear factor-κB ( NF-κB) enters the nucleus and then activates the expression of pro-inflammatory cytokines, causing the immune system to become overactive, causing a cytokine storm, which is of...